I undersøgelse S1 (212) indgik ikke- splenektomerede patienter, som havde en utilfredsstillende respons på tidligere behandlinger, eller som var intolerante over for tidligere behandlinger.
Study S1 (212) evaluated patients who were non-splenectomised and had an inadequate response or were intolerant to prior therapies.